glp-1 shortage fda The says the is over, but a supply cliff is coming for compounded users. Read the report: https://glp-1.reviews/2026-global-glp-1-industry-statistics-the-definitive-data-report-on-pricing-supply-and-provider-integrity/?utm_source=instagram Compound versions of GLP-1 drugs

doi: 10.1038/s41388-024-03098-x 326

Notably, four of the seven core targets were linked to the regulation of ECM deposition and remodeling, processes relevant to atherosclerotic plaque formation

TB-500 studies focus on actin sequestration, reduced inflammatory signaling, and enhanced endothelial and epithelial cell migration

I dont have any patients on a compounded GLP-1, but if I did, and they were taking a pretty high dose, there would be many factors we would discuss

A still unsolved issue, connected with the role of carnitine in modulating gene expression (Figure 1) is the link between mitochondria and nucleus: acetylcarnitine produced in mitochondria would reach the nucleus providing acetyl units (Figure 2)

As a consequence, saxaglitpin treatment should be avoided in patients with heart failure